RVL Pharmaceuticals plc·4

Aug 9, 5:23 PM ET

Schaub James 4

4 · RVL Pharmaceuticals plc · Filed Aug 9, 2022

Insider Transaction Report

Form 4
Period: 2022-08-08
Schaub James
EVP and COO
Transactions
  • Purchase

    Ordinary Shares

    2022-08-08$1.55/sh+150,000$232,500540,020 total

Documents

1 file
  • 4
    tm2222999-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT